EFFICACY OF GUSELKUMAB ACROSS BASDAI COMPONENTS IN TREATING AXIAL-RELATED SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE-3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES

被引：0
|
作者：
Behrens, F. [1 ]
Mease, P. J. [2 ]
Helliwell, P. S. [3 ]
Shawi, M. [4 ]
Noel, W. [5 ]
Chakravarty, S. D. [4 ,6 ]
Kollmeier, A. P. [4 ]
Xu, X. L. [4 ]
Xu, S. [4 ]
Wang, Y. [4 ]
Baraliakos, X. [7 ]
机构：
[1] Goethe Univ, Frankfurt, Germany
[2] Univ Washington, Swedish Med Ctr, Seattle, WA 98195 USA
[3] Univ Leeds, Leeds, W Yorkshire, England
[4] Janssen R&D, Township, PA USA
[5] Janssen R&D, Beerse, Belgium
[6] Drexel Univ, Philadelphia, PA 19104 USA
[7] Ruhr Univ Bochum, Bochum, Germany
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2021年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P158
引用
收藏
页码：1244 / 1245
页数：2
相关论文
共 50 条
  • [1] EFFICACY OF GUSELKUMAB ACROSS BASDAI COMPONENTS IN TREATING AXIAL-RELATED SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Behrens, F.
    Mease, P. J.
    Helliwell, P.
    Shawi, M.
    Noel, W.
    Chakravarty, D.
    Kollmeier, A.
    Xu, X. L.
    Xu, S.
    Wang, Y.
    Baraliakos, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1289 - 1290
  • [2] Efficacy of Guselkumab Across BASDAI Components in Treating Axial-Related Symptoms of Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-controlled Studies
    Behrens, Frank
    Mease, Philip
    Helliwell, Philip S.
    Shawi, May
    Noel, Wim
    Chakravarty, Soumya
    Xu, Alexa Kollmeier Xie
    Xu, Xie
    Xu, Stephen
    Wang, Yanli
    Baraliakos, Xenofon
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3778 - 3780
  • [3] Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study
    Mease, Philip J.
    Gladman, Dafna D.
    Poddubnyy, Denis
    Chakravarty, Soumya D.
    Shawi, May
    Kollmeier, Alexa P.
    Xu, Xie L.
    Xu, Stephen
    Deodhar, Atul
    Baraliakos, Xenofon
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1637 - 1653
  • [4] Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study
    Philip J. Mease
    Dafna D. Gladman
    Denis Poddubnyy
    Soumya D. Chakravarty
    May Shawi
    Alexa P. Kollmeier
    Xie L. Xu
    Stephen Xu
    Atul Deodhar
    Xenofon Baraliakos
    Rheumatology and Therapy, 2023, 10 : 1637 - 1653
  • [5] INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS
    Rahman, P.
    Ritchlin, C.
    Helliwell, P.
    Boehncke, W. H.
    Mease, P.
    Gottlieb, A. B.
    Kafka, S.
    Kollmeier, A.
    Hsia, E.
    Xu, X. L.
    Shawi, M.
    Sheng, S.
    Zhou, B.
    Ramachandran, P.
    McInnes, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1218 - 1218
  • [6] INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS
    Rahman, P.
    Ritchlin, C. T.
    Helliwell, P.
    Boehncke, W. H.
    Mease, P. J.
    Gottlieb, A. B.
    Kafka, S.
    Kollmeier, A.
    Hsia, E. C.
    Xu, X. L.
    Shawi, M.
    Sheng, S.
    Agarwal, P.
    Zhou, B.
    Ramachandran, P.
    Mcinnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 772 - 773
  • [7] GUSELKUMAB EFFICACY IN ADULT PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS BY BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS: POOLED RESULTS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Deodhar, Atul
    Mease, Philip J.
    Boencke, Wolf-Henning
    Tesser, John
    Schiopu, Elena
    Chakravarty, Soumya D.
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Xu, Xie L.
    Shawi, May
    Jiang, Yusang
    Sheng, Shihong
    Agarwal, Prasheen
    Merola, Joseph F.
    McInnes, Iain B.
    Ritchlin, Christopher T.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S108 - S109
  • [8] Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies
    Deodhar, Atul
    Mease, Philip
    Boehncke, Wolf-Henning
    Tesser, John
    Schiopu, Elena
    Chakravarty, Soumya
    Kollmeier, Alexa
    Hsia, Elizabeth
    Xu, Xie
    Shawi, May
    Jiang, Yusang
    Sheng, Shihong
    Agarwal, Prasheen
    Merola, Joseph
    McInnes, Iain
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Trials
    Siebert, Stefan
    Sweet, Kristen M.
    Ritchlin, Christopher T.
    Hsia, Elizabeth C.
    Kollmeier, Alexa P.
    Xu, Xie L.
    Seridi, Loqmane
    Song, Qingxuan
    Gao, Sheng
    Chen, Warner
    Miron, Michelle
    ACR OPEN RHEUMATOLOGY, 2023, 5 (09) : 490 - 498
  • [10] IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB
    Nash, P.
    Mcinnes, I.
    Ritchlin, C. T.
    Tam, L. S.
    Soriano, E.
    Starr, M.
    Rampakakis, E.
    Lavie, F.
    Shawi, M.
    Baraliakos, X.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1771 - 1772
12345